期刊文献+

MiR-486-3p在银屑病皮损的表达及对角蛋白17表达的影响 被引量:6

Expression of miR-486-3p in psoriatic lesions and its effect on keratin 17 expression
原文传递
导出
摘要 目的探讨银屑病患者皮损与健康人皮肤中miR-486-3p表达情况及其对角蛋白17(K17)表达的调控作用。方法采用生物信息学方法预测出调节K17表达的微RNA(microRNA),选取lO例银屑病患者皮损和10例健康人皮肤提取RNA,用加PolyA尾法逆转录为cDNA,实时荧光定量PCR(qRT—PCR)进行荧光定量。用miR-486-3p模拟物(mimics)和阴性对照物(NC)转染人永生化角质形成细胞(HacaT细胞),Western印迹检测K17表达情况;构建双荧光素酶报告系统,其中包括含有K173’UTR的片段,突变1组为将种子序列删除的片段,突变2组为将种子序列间隔突变的片段,突变3组为将种子序列重复2次的片段,并检测miR-486-3p是否与K173UTR种子序列结合而抑制K17表达。结果银屑病皮损中miR-486-3P表达水平为0.211±0.120,低于健康对照的0.555±0.425,银屑病皮损为健康对照的0.380,两组比较,t=2.62,u=9,P〈0.05。Western印迹结果显示,miR-486-3p类似物转染HaCaT细胞后,K17表达水平明显降低。双荧光素酶报告系统检测结果,含有K173’UTR种子序列组与突变3组荧光强度分别为65.31±6.32和54.18±10.01,均低于对照组(P〈0.05);突变1组和突变2组荧光强度分别为114.77±16.14和110.214-12.99,与对照组差异无统计学意义(P〉0.05)。结论miR-486-3p在银屑病皮损中的表达水平低于健康人皮肤,miR-486-3p通过与K173’UTR种子序列结合抑制K17表达,提示其表达水平降低及对K17调控作用的改变可能与银屑病的发生与发展相关。 Objective To determine the expression of miR-486-3p in psoriatic lesions and healthy human skin and to estimate its effect on keratin 17 (KI7) expression in HaCaT human keratinocytes, Methods Bioinformatics was used to predict microRNAs that may affect the expression of K17. Tissue samples were obtained from the lesions of 10 patients with psoriasis and normal skin of 10 healthy human controls. RNA was extracted from these tissue samples and reversely transcribed into cDNA with the addition of a Poly (A) tail. Then, real time quantitative PCR was performed to measure the expression of miR-486-3p. Cultured keratinocytes were transfected with miR-486-3p mimics or negative control, and Western blot was performed to determine K17 expression at 48 hours after the transfection. To evaluate the inhibitory effect of miR-486-3p on K17 expression, cultured 293T cells were transfected with the plasmid containing K17 3' untranslated region (UTR) seed sequence, three plasmids containing the complete deletion, interval mutation or double repeats of the seed sequence, or negative control plasmid. At 24 hours after the transfection, a dualluciferase reporter (DLR) assay was performed to quantify the expression of K17. Results Real time PCR showed that the expression level of miR-486-3p was significantly lower in psoriatic lesions than in the normal skin (0.211± 0.120 vs. 0.555 ± 0.425, t = 2.62, v = 9, P 〈 0.05). The HaCaT cells transfected with the mimics of miR-486-3p exhibited decreased expression of K17 compared with those transfected with the negative control. DLR assay revealed that the expression level (fluorescence intensity) of K17 in the negative control group was significantly higher than that in the 293T ceils transfected with the seed sequence and those with the double repeats of the seed sequence (100.00% vs. 65.31% ± 6.32% and 54.18%± 10.01% respectively, both P 〈 0.05), but did not differ from that in the 293T cells transfected with the complete deletion and interval mutation of the seed sequence (100.00% vs. 114.77% ±16.14% and 110.21% ± 12.99% respectively, both P 〉 0.05). Conclusions The expression of miR-486-3p, which may inhibit K17 expression by binding to the seed sequence of K17 3'UTR, is lower in psoriatic lesions than in normal skin. The decreased expression and inhibitory effect of miR-486-3p may be implicated in the initiation and progression of psoriasis.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2013年第3期160-163,共4页 Chinese Journal of Dermatology
关键词 银屑病 微RNAS 角蛋白17 miR^486~3p Psoriasis MicroRNAs Keratin-17 MiR-486-3p
  • 相关文献

参考文献14

  • 1Ambros V, Lee RC, Lavanway A, et al. MicroRNAs and othertiny endogenous RNAs in C. elegans. Curr Biol, 2003, 13(10):807-818.
  • 2Bartel DP. MicroRNAs: Genomics, Biogenesis, Mechanism, andFunction. Cell, 2004, 116(2): 281-297.
  • 3Leigh IM, Navsaria H, Purkis PE, et al. Keratins (K16 and K17)as markers of keratinocyte hyperproliferation in psoriasis in vivoand in vitro. Br J Dermatol, 1995,133(4): 501-511.
  • 4沈柱,王刚,李巍,刘玉峰.角蛋白17对银屑病患者T细胞增殖和分泌干扰素γ的影响[J].中华皮肤科杂志,2004,37(11):659-661. 被引量:14
  • 5张巍,史晓蔚,呼蕾,王刚.白介素22调控角质形成细胞表达角蛋白17的研究[J].临床皮肤科杂志,2011,40(4):199-202. 被引量:5
  • 6Shi X, Jin L, DangE, et aL IL-17A upregulates keratin 17 expressionin keratinocytes through STAT1-1 and STAT3 - dependentmechanisms. J Invest Dermatol, 2011, 131(12): 2401-2408.
  • 7Shen Z, Chen L,Liu YF,et al. Altered keratin 17 peptideligands inhibit in vitro proliferation of keratinocytes and T cellsisolated from patients with psoriasis. J Am Acad Dermatol, 2006,54(6): 992-1002.
  • 8孙林潮,王刚,王岩,樊建勇,沈柱,陈丹,高天文,刘玉峰.K17反义寡核苷酸对角质形成细胞增殖和K17表达的影响[J].中华皮肤科杂志,2006,39(11):642-644. 被引量:3
  • 9常婷,王大太,孙林潮,王岩,李巍,刘玉峰,高天文,王刚.角蛋白17反义寡核苷酸对银屑病SCID小鼠模型的作用[J].中华皮肤科杂志,2007,40(4):202-205. 被引量:3
  • 10Chang T,Sun L, Wang Y, et al. Inhibition of keratin 17 expressionwith antisense and RNAi strategies: exploring novel therapy forpsoriasis. Exp Dermatol, 2011, 20(7): 555-560.

二级参考文献26

共引文献19

同被引文献83

  • 1崔慧娟,唐元家,罗晓兵,邓筠,郭彦芝,黄新芳,陈顺乐,沈南.系统性红斑狼疮患者中miR-146a表达缺陷与I型干扰素通路过度活化相关[J].现代免疫学,2008,28(4):279-284. 被引量:13
  • 2沈柱,王刚,樊建勇,李巍,刘玉峰.人角蛋白17的HLA-DR限制性T细胞表位区的确定[J].中华微生物学和免疫学杂志,2004,24(10):769-772. 被引量:5
  • 3王岩,王刚,刘玉峰,孙林潮,沈柱.靶向角蛋白17基因的小干涉RNA对角质形成细胞增生与凋亡的影响[J].中国皮肤性病学杂志,2006,20(4):201-203. 被引量:4
  • 4常婷,王大太,孙林潮,王岩,李巍,刘玉峰,高天文,王刚.角蛋白17反义寡核苷酸对银屑病SCID小鼠模型的作用[J].中华皮肤科杂志,2007,40(4):202-205. 被引量:3
  • 5Jin L, Wang G. Keratin 17: A critical player in the pathogenesis of psoriasis[J]. Med Res Rev, 2014, 34(2): 438-454.
  • 6Zhang W, Dang E, Shi X, et al. The pro-inflammatory eytokine IL-22 up-regulates keratin 17 expression in keratinoeytes via STAT3 and ERK12 [J/OLI. PLoS One, 2012, 7 (7): e4079712011-10- 10]. htto://www.ncbi.nlm.nih.zov/ome/articles/PMC3396590L.
  • 7Fu M, Wang G. Keratin 17 as a therapeutic target for the treatment of psoriasis[J]. J Dermatol Sci, 2012, 67(3): 161-165.
  • 8Shen Z, Wang G, Fan JY, et al. HLA DR Bl*04,*07-restricted epitopes on Keratin 17 for autoreactive T cells in psoriasis [J]. J Dermatol Sci, 2005, 38( 1 ): 25-39.
  • 9Erkin G, Ugur Y, Gurer CK, et al. Effect of PUVA, narrow-band UVB and cyclosporin on inflammatory cells of the psoriatic plaque[J]. J Cutan Pathol, 2007, 34(3): 213-219.
  • 10Chen X, Yang M, Cheng Y, et al. Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet B or psoralen- ultraviolet A photochemotherapy for psoriasis [J]. Cochrane Database Syst Rev, 2013, 10: CD009481.

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部